Lv11
38 积分 2022-11-07 加入
MEK inhibitors in oncology: a patent review and update (2016 - present)
9小时前
已完结
Structure of mitogen-activated protein kinase kinase 1 in the DFG-out conformation
2天前
求助中
Methotrexate exerts antitumor immune activity and improves the clinical efficacy of immunotherapy in patients with solid tumors
19天前
已完结
Combinatorial strategies to target RAS-driven cancers
3个月前
已完结
Updated patent review for Hematopoietic progenitor kinase (HPK1) inhibitors and degraders (2021-present)
7个月前
已完结
222 Lurbinectedin (PM01183): Pharmacokinetics/Pharmacodynamic (PK/PD) Properties in Pancreas, Ovarian and NSCLC Xenografts
7个月前
已完结
Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients
7个月前
已完结
MDM2-PROTAC versus MDM2 Inhibitors: Beyond p53 Reactivation
8个月前
已完结
DihydrofolateReductase (DHFR) Inhibitors: A Comprehensive Review
1年前
已完结
Recent advances in the development of STING inhibitors: an updated patent review
1年前
已完结
皖公网安备34019202002308
